What APC Genetic Testing Checks For
APC genetic testing is a blood or saliva test that looks for inherited changes in the APC gene. The APC gene normally keeps cell growth in check, but certain mutations cause cells to form hundreds or thousands of polyps in the colon and rectum. Without intervention, these polyps almost always become cancerous, often by age 40 or 50. Testing confirms whether a person carries a disease-causing variant and helps families understand their hereditary risk for colorectal cancer and polyposis syndromes.
More from this site
Keep reading the latest coverage
Who Should Consider APC Genetic Testing
Guidelines from groups such as the National Comprehensive Cancer Network recommend testing when a person has a personal or family history that raises suspicion for an APC-related condition. Common indicators include: more than 100 colorectal polyps found during a colonoscopy, a diagnosis of familial adenomatous polyposis (FAP) or attenuated FAP, or a known APC mutation in a blood relative. Testing may also be considered for individuals with early-onset colorectal cancer, especially before age 50, or multiple cases of colorectal or duodenal polyps on the same side of the family. A genetic counselor helps determine whether testing is appropriate based on family history patterns and cancer registries.
How the Testing Process Works
The process starts with a counseling session to review personal and family medical history, explain possible outcomes, and discuss the implications for relatives. A sample of blood or saliva is sent to a specialized lab, where technicians extract DNA and sequence the APC gene. Results typically take two to four weeks and are reported as one of three categories: a pathogenic or likely pathogenic variant is found, no pathogenic variant is identified, or a variant of uncertain significance is detected. Each result carries different medical and family-planning implications, which a counselor walks through in a follow-up visit.
What Results Mean for Health Management
A confirmed APC mutation changes the surveillance and prevention plan. For people with classic FAP, doctors often recommend prophylactic removal of the colon because the risk of colorectal cancer is nearly 100 percent by middle age. Attenuated FAP, associated with fewer polyps and later onset, may call for earlier and more frequent colonoscopies, upper endoscopies to check the duodenum, and periodic imaging of the stomach and small bowel. Even when testing finds no mutation in someone from a known FAP family, the person's screening schedule can often be relaxed to match the general population, which provides significant relief. A variant of uncertain significance requires careful interpretation because it is not yet clear whether it causes disease.
Implications for Family Members
Because APC mutations are autosomal dominant, each child of a carrier has a 50 percent chance of inheriting the variant. Once a causative mutation is identified in one family member, targeted testing of at-risk relatives becomes straightforward and less expensive. A negative result in a relative who previously lived under the shadow of family cancer risk allows that person to return to standard age-based screening. Cascade testing — systematically checking blood relatives — is one of the most powerful ways genetic information prevents cancer deaths, by catching polyps before they turn malignant.
Limitations and Practical Considerations
APC testing does not detect every possible mutation; large deletions or rearrangements in the gene can be missed by standard sequencing and require separate deletion/duplication analysis. A negative test does not rule out a polyposis syndrome caused by other genes, such as MUTYH, or by spontaneous mutations that are not inherited. Cost, insurance coverage, and potential discrimination concerns vary by location and plan, though laws such as the Genetic Information Nondiscrimination Act in the United States provide some protections. Testing a person who already has cancer, when possible, is often more informative than testing an unaffected relative first, because it confirms the family's variant and gives at-risk members a clear target for analysis.
Looking Ahead: Precision Prevention
APC genetic testing sits at the intersection of hereditary cancer risk and precision prevention. A confirmed result gives a clear roadmap — earlier colonoscopies, risk-reducing surgery in some cases, and a defined schedule for upper endoscopies and imaging. It also arms family members with knowledge they can act on years before cancer appears. As multigene panel testing becomes more common, the APC result is often one piece of a larger picture that includes other polyposis and cancer-predisposition genes, and genetic counselors integrate all of it into a single, personalized plan.